Evidence map›Paper›PMID 42920161›Full record

ArticleArchives of public health = Archives belges de sante publique2026

Advancing women's health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment.

Khaled Abdelghaffar, Mohamed Hassany, Hesham Elghazaly, Hatem Amin, Ahmed Morsi, Emad Shash, Ahmed H Abdelaziz, Loay Kassem, Nany Omar, Dalia Shaltout and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Khaled AbdelghaffarMinistry of Health and Population, Cairo, Egypt.
Mohamed HassanyMinistry of Health and Population, Cairo, Egypt.
Hesham ElghazalyDepartment of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Hatem AminDepartment of Oncosurgery, Ministry of Health and Population, Cairo, Egypt.
Ahmed MorsiDepartment of Clinical Oncology, Gustave Roussy International, Cairo, Egypt.
Emad ShashDepartment of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
Ahmed H AbdelazizDepartment of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Loay KassemDepartment of Clinical Oncology, Cairo University Hospitals, Cairo, Egypt.
Nany OmarWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Dalia ShaltoutWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Salma Mohamed MostafaWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Alaa AshrafWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Mohamed Abo Bakr AwadWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Rana Elsayed BendaryWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Howaida KhalilWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Salwa GazarWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Bassant AtefWomen's Health Initiative, Ministry of Health and Population, Cairo, Egypt.
Ahmed IbrahimAccsight, Cairo, Egypt.
Islam AnanAccsight, Cairo, Egypt. islam.anan@accsight.com.ORCID http://orcid.org/0000-0002-0697-6464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer (BC) is the leading cause of cancer-related mortality among women worldwide and poses a major public health and economic challenge in Egypt, where late-stage diagnosis remains high. Egypt launched the Presidential Initiative for Women's Health, a nationwide, publicly funded program providing free early detection, diagnostic, and treatment services. This study presents a model-based economic evaluation of the initiative.

methodsA hybrid decision tree and Markov model compared the Presidential Initiative pathway with opportunistic case detection, from a societal perspective over a lifetime horizon. Outcomes were quality-adjusted life years (QALYs), life years, net societal cost, and return on investment (ROI); health outcomes were not monetized. Model structure was assessed using face, internal, and cross-validation following the ISPOR-SMDM taxonomy with structured review by 16 clinical and program co-authors. Uncertainty was examined using Monte Carlo probabilistic sensitivity analysis (PSA) with 5000 iterations. Inputs were national program data for July 2019 to September 2024.

resultsApproximately 23.8 million unique women generated 53,453,745 recorded screening and service encounters. Among confirmed cases, the observed stage I to II proportion was 61.3% in the initiative data versus 41.6% in the comparator. The model estimated 32,576 incremental QALYs and 63,448 additional discounted life years, with total societal costs of EGP 11.68 billion (USD 258 million) versus EGP 18.07 billion (USD 398 million), a net societal saving of EGP 6.39 billion (USD 141 million) and an ROI of 54.7%. In the PSA, at the Egyptian threshold of EGP 164,588 per QALY, the initiative was cost-effective in all 5,000 simulations (100%), and dominant in 4,988 (99.76%), with a base-case net monetary benefit of EGP 11.75 billion (USD 259 million).

conclusionsUnder the observed program stage distribution, the Presidential Initiative was projected to provide greater modeled health outcomes at lower societal cost than opportunistic case detection, dominant in the base-case and cost-effective at the Egyptian threshold in every simulation. These are model-based estimates conditional on transferred survival and utility inputs. The findings support continued program evaluation and investment alongside collection of Egyptian long-term outcome data.

Indexed as

Breast cancerCost-utility analysisEarly detectionEgyptProbabilistic sensitivity analysisScreening programs

Identifiers

PMID42920161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.